Filing Flows › Harvard Apparatus Regenerative Technology (HRGN) › Q1 2026 › vs Q1 2025
Harvard Apparatus Regenerative Technology (HRGN) Q1 2026 vs Q1 2025 (year over year)
Harvard Apparatus Regenerative Technology's revenue rose $181K (+402%) from $45K in Q1 2025 to $226K in Q1 2026.
Harvard Apparatus Regenerative Technology, Q1 2026: revenue $226K (+402% year over year), operating margin -710.6%, net loss $1.6M, operating cash flow −$937K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $226K | $45K | $181K | +402% |
| Other income, net | $5K | $11K | −$6K | -55% |
| Net loss | $1.6M | $1.7M | −$58K | -3% |
| Costs & expenses | $1.8M | $1.7M | $117K | +7% |
| Operating costs | $1.8M | $1.7M | $117K | +7% |
| Cost of revenue | $206K | $33K | $173K | +524% |
| Research & development | $563K | $601K | −$38K | -6% |
| General & admin | $1.0M | $1.1M | −$26K | -2% |
| Operating cash sources | $1.6M | $1.7M | −$58K | -3% |
| Depreciation | $1K | $2K | −$1K | -50% |
| Share-based compensation | $632K | $485K | $147K | +30% |
| Working capital & other | $31K | $414K | −$383K | -93% |
| Cash used in operations | $937K | $758K | $179K | +24% |
| Net loss absorbed | $1.6M | $1.7M | −$58K | -3% |
Questions
How much did Harvard Apparatus Regenerative Technology's revenue grow year over year in Q1 2026?
Harvard Apparatus Regenerative Technology's revenue rose $181K (+402%) from $45K in Q1 2025 to $226K in Q1 2026.